ATE254173T1 - P75 tnf-rezeptor-promotoren - Google Patents

P75 tnf-rezeptor-promotoren

Info

Publication number
ATE254173T1
ATE254173T1 AT95919786T AT95919786T ATE254173T1 AT E254173 T1 ATE254173 T1 AT E254173T1 AT 95919786 T AT95919786 T AT 95919786T AT 95919786 T AT95919786 T AT 95919786T AT E254173 T1 ATE254173 T1 AT E254173T1
Authority
AT
Austria
Prior art keywords
promotors
tnf receptor
sequence
upstream
preparation
Prior art date
Application number
AT95919786T
Other languages
English (en)
Inventor
David Wallach
Peter Kuhnert
Gotz Ehrhardt
Oliver Kemper
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE254173T1 publication Critical patent/ATE254173T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95919786T 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren ATE254173T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL10963394A IL109633A (en) 1994-05-11 1994-05-11 Tnf receptor promoter
PCT/US1995/005853 WO1995031206A1 (en) 1994-05-11 1995-05-11 P75 tnf receptor promoters

Publications (1)

Publication Number Publication Date
ATE254173T1 true ATE254173T1 (de) 2003-11-15

Family

ID=11066126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95919786T ATE254173T1 (de) 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren

Country Status (13)

Country Link
EP (1) EP0759759B1 (de)
JP (1) JP3663211B2 (de)
AT (1) ATE254173T1 (de)
AU (1) AU699280B2 (de)
CA (1) CA2189984C (de)
CY (1) CY2524B1 (de)
DE (1) DE69532115T2 (de)
DK (1) DK0759759T3 (de)
ES (1) ES2206505T3 (de)
IL (1) IL109633A (de)
PT (1) PT759759E (de)
WO (1) WO1995031206A1 (de)
ZA (1) ZA953841B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
RU2640115C2 (ru) 2011-11-01 2017-12-26 Ресверлоджикс Корп. Фармацевтические композиции замещенных хиназолинонов
WO2014046247A1 (ja) * 2012-09-20 2014-03-27 東亞合成株式会社 １型ｔｎｆ受容体と２型ｔｎｆ受容体の存在バランスを調節する合成ペプチド及びその利用

Also Published As

Publication number Publication date
AU2546895A (en) 1995-12-05
DE69532115D1 (de) 2003-12-18
IL109633A (en) 2005-05-17
CA2189984C (en) 2008-03-25
PT759759E (pt) 2004-01-30
EP0759759A1 (de) 1997-03-05
CY2524B1 (en) 2006-02-08
JP3663211B2 (ja) 2005-06-22
AU699280B2 (en) 1998-11-26
JPH10500304A (ja) 1998-01-13
EP0759759B1 (de) 2003-11-12
IL109633A0 (en) 1994-08-26
ES2206505T3 (es) 2004-05-16
ZA953841B (en) 1996-01-17
EP0759759A4 (de) 1997-11-26
CA2189984A1 (en) 1995-11-23
DE69532115T2 (de) 2004-08-26
DK0759759T3 (da) 2004-02-02
WO1995031206A1 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
WO1992013950A3 (fr) SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
NO951138D0 (no) Mikropartikkelpreparater fremstilt fra biologisk nedbrytbare blandingspolymerer
EP0675225A3 (de) Weiches einlagiges Seidenpapier mit sehr niedriger Oberseite/Unterseite-Asymetrie.
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
BG103169A (en) Ligand related to tumour necrotic factor
IL106894A0 (en) Dorsal tissue affecting factor and compositions
DE69532115D1 (de) P75 tnf-rezeptor-promotoren
MY106522A (en) Arylaminocarbonyl compounds.
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
ZA966489B (en) New protein human MP52 Arg.
ZA969645B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.
ZA200202823B (en) Self-cleaving RNA sequences and their use for the control of protein synthesis.
ITMI942671A0 (it) Catalizzatori per la (co) polinerizzazione dell'etilene
GB2325466A (en) Nucleotide sequence from goat liver
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano
ITTO920958A1 (it) Doccia per uso terapeutico.
CA2038030A1 (en) Synthetic peptides which contain sequences from factor viia, and the use thereof
ITRM950130V0 (it) Bidet con rubinetto disposto frontalmente all'utilizzazione.
McNamee Voiceprints
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
FR2717073B1 (fr) Bac à shampoing pour malades allongés, notamment pour grabataires.
FR2703251B3 (fr) Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0759759

Country of ref document: EP

REN Ceased due to non-payment of the annual fee